• Quick Courses
• On-demand
• Live
• Physicians
• Nurses/Case Managers/Social Workers
• Pharmacists

Hemophilia Clinical Updates and Cost Management Solutions – Certified for Nurses, Pharmacists, and Physicians

Up to  1.25 credit hour available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

• Describe recent insights into the safety, efficacy, and attributes of recently approved and emerging hemophilia treatment options
• Review alignment of recently approved therapies in the current hemophilia treatment algorithm
• Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences
• Apply processes for managed care and specialty pharmacy professionals to improve communications and collaborations with HTCs

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/clinical-updates-cost-management-solutions-ce/

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Shire, now part of Takeda.

---

Latest Hemophilia Insights – Certified for Nurses, Pharmacists, and Physicians

Up to  1.0 credit hour available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

• Describe recent insights into the safety, efficacy and attributes of recently approved and emerging hemophilia treatment options.
• Review alignment of recently approved therapies in the current hemophilia treatment algorithm.
• Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences.
• Apply processes for managed care organizations and specialty pharmacy providers to improve communications and collaborations with HTCs.

And don’t miss this presentation by:

Mark T. Reding, MD
Associate Professor of Medicine
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/insights

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Shire, CSL Behring, and Novo Nordisk, Inc.

---

Quick CE Activity for Nurses, Pharmacists, and Physicians

Up to  0.5 credit hours available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

• Discuss the unique Medicaid considerations for the coverage, reimbursement, and cost management of hemophilia services
• Evaluate various programs that States are implementing to manage the care and costs for patients with hemophilia

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/medicaidmanagement

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Postgraduate Institute for Medicine.
This activity is supported by an independent educational grant from Shire.

---

Quick CE Activity for Nurses, Pharmacists, and Physicians

Up to  0.5 credit hours available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

• Describe the integrated and coordinated care that is provided by hemophilia treatment centers (HTCs)
• Apply processes for managed care organizations and specialty pharmacy providers to improve communications and collaborations with HTCs

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/casemanagement

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Postgraduate Institute for Medicine.
This activity is supported by an independent educational grant from Shire.

---

Free CE Activity for Nurses, Pharmacists, and Physicians

Up to  1.25 credit hours available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

• Describe recent insights into the safety, efficacy, and attributes of recently approved and emerging hemophilia treatment options
• Align recently approved therapies into the current hemophilia treatment algorithm
• Explain hemophilia‐related complications associated with inhibitor development and its significant clinical and economic consequences
• Apply processes for managed care organizations and specialty pharmacy providers to improve communications and collaborations with hemophilia treatment centers (HTCs)

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/costmanagement

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Postgraduate Institute for Medicine.
This activity is supported by independent educational grants from Novo Nordisk, Inc., CSL Behring, and Shire.

---

Free CE Activity for Pharmacists

Certified for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education. 

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

• Describe recent insights into the safety, efficacy, and attributes of recently approved and emerging hemophilia treatment options
• Review alignment of recently approved therapies in the current hemophilia treatment algorithm
• Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences
• Apply processes for specialty pharmacy providers to improve communications and collaborations with hemophilia treatment centers (HTCs)

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/specialty

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Postgraduate Institute for Medicine.
This activity is supported by independent educational grants from Shire and CSL Behring.

---